Redox redux: Protecting the ischemic myocardium

Journal of Clinical Investigation

Volumn 122, Issue 1, 2012, Pages 30-32

  Spindel, Oded N ^a   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; THIOREDOXIN 1; THIOREDOXIN 2; THIOREDOXIN INTERACTING PROTEIN;

BIOAVAILABILITY; BIOENERGY; CATALYSIS; CELL ENERGY; ENERGY METABOLISM; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; MITOCHONDRIAL RESPIRATION; NONHUMAN; NOTE; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; FEMALE; HUMANS; MALE; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; THIOREDOXINS;

EID: 84855430939     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI61467     Document Type: Note

References (23)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357 (11):1121-1135. View this article via: PubMed CrossRef
2. Yamawaki H, Pan S, Lee RT, Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest. 2005;115(3):733-738. View this article via: JCI.org PubMed (Pubitemid 40322249)
3. Wang Y, De Keulenaer GW, Lee RT. Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem. 2002;277(29):26496-26500. View this article via: PubMed (Pubitemid 34967145)
4. Yoshioka J, et al. Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. J Clin Invest. 2012;122(1):267-279. JCI.org
5. Di Lisa F, Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res. 2006;70(2):191-199. View this article via: PubMed CrossRef
6. Yu FX, Chai TF, He H, Hagen T, Luo Y. Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate. J Biol Chem. 2010;285(33):25822-25830. View this article via: PubMed CrossRef
7. Hui ST, et al. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc Natl Acad Sci U S A. 2008;105(10):3921-3926. View this article via: PubMed CrossRef (Pubitemid 351723500)
8. Saxena G, Chen J, Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem. 2010;285(6):3997-4005. View this article via: PubMed CrossRef
9. World CJ, Yamawaki H, Berk BC. Thioredoxin in the cardiovascular system. J Mol Med. 2006;84(12):997-1003. View this article via: PubMed
10. Spindel ON, World C, Berk B. Thioredoxin Interacting Protein (TXNIP): Redox dependent and independent regulatory mechanisms [published online ahead of print September 19, 2011]. Antioxid Redox Signal.doi:10.1089/ars.2011.4137. View this article via: PubMed
11. Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res. 2005;65 (11):4485-4489. View this article via: PubMed (Pubitemid 40740780)
12. Ago T, et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell. 2008;133(6):978-993. View this article via: PubMed (Pubitemid 351787743)
13. Shin D, et al. VDUP1 mediates nuclear export of HIF1alpha via CRM1-dependent pathway. Biochim Biophys Acta. 2008;1783(5):838-848.View this article via: PubMed CrossRef
14. World C, Spindel ON, Berk BC. Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species. Arterioscler Thromb Vasc Biol. 2011;31(8):1890-1897. View this article via: PubMed
15. Rauch S, Martin-Serrano J. Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding. J Virol. 2011;85 (7):3546-3556. View this article via: PubMed CrossRef
16. Alvarez CE. On the origins of arrestin and rhodopsin. BMC Evol Biol. 2008;8:222. View this article via: PubMed CrossRef
17. Chutkow WA, Lee RT. Thioredoxin regulates adipogenesis through thioredoxininteracting protein (Txnip) protein stability. J Biol Chem. 2011;286(33):29139-29145. View this article via: PubMed
18. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136-140. View this article via: PubMed
19. Chen J, Saxena G, Mungrue IN, Lusis AJ, Shalev A. Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis. Diabetes. 2008;57 (4):938-944. View this article via: PubMed CrossRef
20. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxininteracting protein. J Biol Chem. 2004;279(29):30369-30374. View this article via: PubMed (Pubitemid 38937964)
21. Perrone L, Devi TS, Hosoya K, Terasaki T, Singh LP. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol. 2009;221 (1):262-272. View this article via: PubMed CrossRef
22. Li X, et al. Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem Biophys Res Commun. 2009;381(4):660-665. View this article via: PubMed CrossRef
23. Chen CL, Lin CF, Chang WT, Huang WC, Teng CF, Lin YS. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin- interacting protein-mediated pathway. Blood. 2008;111(8):4365-4374. View this article via: PubMed CrossRef